Results 161 to 170 of about 58,918 (233)

The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation. [PDF]

Clin Infect Dis
Ahmed MM, Joerger T, Wang Z, Li Y, Gerber JS.   +4 more
europepmc   +1 more source

Research priorities in chronic lung allograft dysfunction: A machine learning-assisted bibliometric analysis. [PDF]

JHLT Open
El Husseini K, Delin M, Decaux S, Goletto T, Morer L, Mouren D, Salpin M, Weisenburger G, Coiffard B, Merveilleux du Vignaux C, Le Pavec J, Renaud-Picard B, Roux A, Tissot A, Villeneuve T, Roussel A, Mordant P, Brugière O, Mal H, Bunel V.   +19 more
europepmc   +1 more source

Hospital Admissions for Respiratory Syncytial Virus (RSV) Among Elderly: A Retrospective Study From an Italian Southern Region During Years 2018-2023. [PDF]

Influenza Other Respir Viruses
Di Martino G, Di Giovanni P, Vaccaro F, Cascavilla FR, Di Marzio C, Tognaccini L, Trebbi E, Aita T, Romano F, Staniscia T.   +9 more
europepmc   +1 more source

Bridging the Gap between Evidence and Clinical Practice in the Management of Acute Viral Bronchiolitis: Insights from the PRERNI-PAVB Survey. [PDF]

Indian J Crit Care Med
Subramani S, Chidambaram M.
europepmc   +1 more source

Lung ultrasound versus chest X-ray in pediatric lower respiratory tract infections at a tertiary center: a prospective observational study. [PDF]

Ital J Pediatr
Elmeazawy R, Aborady AA, Abd-Razik AM, Erfan AA, Eltomey MA, Hamza MB.   +5 more
europepmc   +1 more source

Respiratory Syncytial Virus Disease Burden and Evidence Gaps in Australia Before Immunisation Introduction: A Retrospective Population-Based Study Using 2016-2019 Hospitalisation and 2023 Laboratory Surveillance Data. [PDF]

Med J Aust
Imai-Boulter C, Li-Kim-Moy J, Chiu C, Jayasinghe S, Macartney K.   +4 more
europepmc   +1 more source

Current approaches to acute bronchiolitis management among pediatricians: guideline adherence and practice variation. [PDF]

BMC Pediatr
Üzüm Ö, Totur G, Eliaçık K, Kanık A.   +3 more
europepmc   +1 more source

Safety of nirsevimab in children aged 0-24 months: Analysis based on EudraVigilance data (2023-2025). [PDF]

Hum Vaccin Immunother
Morciano C, Annunziata A, Cutillo M, Mayer F, Spila Alegiani S.   +4 more
europepmc   +1 more source